Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Value Stock, Under Radar
846.1000 -6.65 (-0.78%)
NSE Sep 08, 2025 15:31 PM
Volume: 349.1K
 

logo
Natco Pharma Ltd.
21 Nov 2018
846.10
-0.78%
Geojit BNP Paribas
NATCO Pharma (NATCO) is a R&D; focussed, vertically integrated pharmaceutical company with an experienced management team and presence across multiple speciality therapeutic segments. Q2FY19 revenue grew by 35% YoY due to stronger performance from API (up by 30%YoY) and formulation (up by 96%YoY) exports. EBITDA rose by 104% YoY while margin is up by 1520bps primarily driven by revenue from limited competition products in the US. Received court affirmation in favor of prior decisions invalidating...
Number of MF schemes decreased from 54 to 47 in Jun 2025 qtr
More from Natco Pharma Ltd.
Recommended